Elanco Animal Health (ELAN) Director R David Hoover Acquires 20,000 Shares

Elanco Animal Health (NASDAQ:ELAN) Director R David Hoover bought 20,000 shares of the company’s stock in a transaction dated Wednesday, March 13th. The shares were acquired at an average cost of $31.43 per share, with a total value of $628,600.00. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink.

Shares of ELAN traded up $0.33 during mid-day trading on Friday, reaching $30.64. The stock had a trading volume of 30,687,228 shares, compared to its average volume of 9,839,696. Elanco Animal Health has a 52-week low of $28.00 and a 52-week high of $37.61.

Elanco Animal Health (NASDAQ:ELAN) last announced its quarterly earnings data on Wednesday, February 6th. The company reported $0.29 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.26 by $0.03. The firm had revenue of $799.30 million during the quarter, compared to analysts’ expectations of $804.07 million. During the same period in the prior year, the company posted $0.12 EPS. The company’s revenue for the quarter was up 6.0% compared to the same quarter last year.

ELAN has been the subject of a number of analyst reports. William Blair initiated coverage on shares of Elanco Animal Health in a report on Monday, February 11th. They issued a “market perform” rating and a $29.71 price objective for the company. UBS Group initiated coverage on shares of Elanco Animal Health in a report on Wednesday, January 23rd. They issued a “sell” rating and a $29.00 price objective for the company. Argus initiated coverage on shares of Elanco Animal Health in a report on Tuesday, January 15th. They issued a “buy” rating and a $37.00 price objective for the company. Credit Suisse Group reissued a “hold” rating and issued a $33.00 price objective on shares of Elanco Animal Health in a report on Friday, January 4th. Finally, Morgan Stanley initiated coverage on shares of Elanco Animal Health in a report on Wednesday. They issued an “equal weight” rating and a $34.00 price objective for the company. One investment analyst has rated the stock with a sell rating, eight have issued a hold rating and five have assigned a buy rating to the stock. The stock presently has an average rating of “Hold” and an average price target of $33.48.

A number of hedge funds have recently made changes to their positions in the business. American Century Companies Inc. boosted its stake in Elanco Animal Health by 142.5% during the fourth quarter. American Century Companies Inc. now owns 2,077,810 shares of the company’s stock worth $65,513,000 after buying an additional 1,220,878 shares during the period. Geode Capital Management LLC purchased a new position in Elanco Animal Health during the fourth quarter worth about $18,592,000. Norges Bank purchased a new position in Elanco Animal Health during the fourth quarter worth about $60,526,000. FMR LLC boosted its stake in Elanco Animal Health by 34.5% during the fourth quarter. FMR LLC now owns 4,415,172 shares of the company’s stock worth $139,210,000 after buying an additional 1,131,504 shares during the period. Finally, Penn Capital Management Co. Inc. boosted its stake in Elanco Animal Health by 35.9% during the fourth quarter. Penn Capital Management Co. Inc. now owns 46,748 shares of the company’s stock worth $4,268,000 after buying an additional 12,352 shares during the period.

ILLEGAL ACTIVITY NOTICE: “Elanco Animal Health (ELAN) Director R David Hoover Acquires 20,000 Shares” was published by The Lincolnian Online and is the sole property of of The Lincolnian Online. If you are viewing this report on another site, it was stolen and reposted in violation of US and international trademark and copyright legislation. The legal version of this report can be viewed at https://www.thelincolnianonline.com/2019/03/15/elanco-animal-health-elan-director-r-david-hoover-acquires-20000-shares.html.

About Elanco Animal Health

There is no company description available for Elanco Animal Health Inc

Recommended Story: What is Put Option Volume?

Receive News & Ratings for Elanco Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elanco Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.